Association between low bone mass and the serum RANKL and OPG in patients with nephrolithiasis

Association between low bone mass and the serum RANKL and OPG in patients with nephrolithiasis

Abstract Background Nephrolithiasis is a risk factor for Osteopenia and osteoporosis. Receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin (OPG) regulate bone remodeling and osteoclastogenesis. This study aimed to evaluate the relation between serum OPG, RANKL concentration...

Full description

Bibliographic Details
Main Authors: Asieh Mansour, Maryam Aboeerad, Mostafa Qorbani, Amir Pejman Hashemi Taheri, Mohamad Pajouhi, Abbas Ali Keshtkar, Bagher Larijani, Mohammad Reza Mohajeri-Tehrani, Mohammad Reza Ganji
Format: Article
Language:English
Published: BMC 2018-07-01
Series:BMC Nephrology
Subjects:
Low bone mass
Osteopenia
Osteoporosis
BMD
OPG
RANKL
Online Access:http://link.springer.com/article/10.1186/s12882-018-0960-z

Internet

http://link.springer.com/article/10.1186/s12882-018-0960-z

Similar Items